Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31915 total
Acadia Healthcare heads into late September with a striking divergence: the stock is up 7% on the week and options traders have turned the most bullish they've been all year, yet short sellers are still sitting on 24%…
Marathon Petroleum closes the week down 5.2% at $389.68, with the stock retreating from its recent highs even as the bull thesis from Goldman Sachs and Morgan Stanley remains formally intact — the week's defining…
Nebius Group heads into the back half of September with a genuinely contradictory setup: the stock just gained 14% in a week, yet shorts are adding to positions, a new sell-side initiation carries an $84 target against…
Huntington Ingalls Industries enters the final stretch of Q3 with a notable disconnect: the stock just posted its strongest quarterly earnings reaction in recent memory, yet analysts keep trimming targets and options…
HCA Healthcare enters the final month before its October 23 earnings with a fresh analyst initiation pulling against an options market that has quietly flipped more defensive — the most interesting tension of the…
Meta Platforms has surged 10% this week to $736.60 — and the Street is scrambling to catch up. The standout story is the volume and direction of analyst revisions. Five firms raised their price targets in the past 48…
Pacira BioSciences enters the final stretch of Q3 with an activist holder on its register, two fresh analyst initiations pulling in opposite directions, and short interest quietly grinding toward an 18-month high — a…
Targa Resources finds itself in an increasingly uncomfortable position: the analyst community just delivered its most emphatic endorsement of the year, yet the stock has continued to drift lower, now trading 6% below…
VOO has staged a meaningful recovery this week, yet the options market that last week was signalling peak defensiveness hasn't changed its view — a divergence worth sitting with. The fund gained 2.4% on the week to…
AMLP heads into the final week of September with short sellers unwinding positions at a notable clip — the clearest story in an otherwise quiet week for the Alerian MLP ETF. The retreat in short positioning is the…
Tesla ends the week up 6.3% — its best weekly gain in months — yet the options market is quietly hedging more than usual, a split that frames the setup heading into the October 21 earnings date. The most notable shift…
COPX has snapped back hard this week, rising 6.4% to $89.98 — and the short sellers who piled in during last week's selloff are now on the wrong side of the move. The reversal is striking given the context. The…
JKS heads into the final week of September with short interest near a one-month high, options sentiment shifted sharply toward caution, and a stock that has now shed 34% in a single month — all against the backdrop of…
CorMedix enters the final stretch before its November 11 earnings with a rare combination: short interest still running at a structurally elevated level, yet shorts themselves are quietly trimming, even as options…
VEON enters the final week of September carrying a sharp tension: the options market has swung to its most aggressively bullish posture of the past year, even as borrowing costs have surged almost 100x from where they…
General Motors is drifting lower against a backdrop of compressing multiples, a stock down 5% on the month, and an October 20 earnings date that is now less than four weeks away. The valuation story is the clearest…
SCHE enters the final week of September with an unusual combination: a strong one-week rally and options positioning that has swung to its most bullish extreme in months. The price story is straightforward. SCHE closed…
GNRC enters the final week of September with the Amazon deal euphoria fully digested — and the stock sitting at $206.17, nearly flat from last Friday's close of $207.44, while a renewed round of analyst target-raising…
FTNT has added another 1.1% this week to $174.26, pushing further above the average analyst price target and widening a valuation gap that the Street is showing little urgency to close. The price-versus-conviction…
Dollar General heads into the final stretch of September with one clear tension: options traders have turned notably less defensive even as the stock slips on the week, while short sellers continue their retreat. The…
